What Do Device Investors Want?
This article was originally published in Start Up
Executive Summary
Perhaps the question most often posed by entrepreneurs and start-up company executives is, "What are device investors looking for these days?" At Windhover's recent IN3 West conference, industry leaders provided several different perspectives on that question. In this article, we excerpt portions of a discussion that featured two prominent organizations with long-term commitments to medical device investing, but which operate from different points on the investor spectrum: Medtronic Inc. and the Carlyle Group.
You may also be interested in...
Carlyle Expands Device Venture Finance Group
When most industry people hear of The Carlyle Group, they think of it exclusively as a buyout group, and indeed leveraged buyouts are an important part of the global private equity firm's business. But many are surprised to learn that Carlyle has a venture and growth capital operation that maintains a strong commitment to investing in the medical device sector.
Medtronic: Ready to Deal Again
A decade ago, Medtronic shook up itself and the device industry with a series of large deals over a short period of time. In the process, the company tranformed itself from a leader in cardiac rhythm management into the industry's largest, most diversified device company. More recently, the company has been quieter, focusing on smaller deals, both acquisitions and minority investments. In But in this interview, Medtronic's head of Corporate Development, Bob White, says that Medtronic is ready to deal again and talks about the kinds of companies it's interested in.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.